Tukysa (Tucatinib Tablet) 150mg

Tukysa (tucatinib) 150mg tablets are a prescription therapy for certain breast cancers. This targeted treatment is designed to inhibit cancer cell growth. Suitable for patients seeking advanced cancer care options.

Strength

150mg

Pack Size

84s

Storage

Ambient

Manufacturer / TM Owner

Seagen Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tukysa (tucatinib) is used to treat HER2-positive breast cancer, a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2. It is often prescribed in combination with other medications to slow or stop the growth of cancer cells. Patients may ask, 'what is Tukysa used for' to understand its role in their treatment plan.

Side Effects

Tukysa works by targeting specific proteins in cancer cells, which may help reduce tumor size or slow its progression. Common effects include gastrointestinal discomfort or fatigue, though individual responses vary. It is not a cure but may help manage symptoms in some cases.

Precautions & Warnings

Store Tukysa tablets at room temperature away from moisture and heat. Keep out of reach of children and pets. Patients should discuss their full medical history with a healthcare provider before starting treatment. Avoid crushing or splitting tablets unless advised otherwise.

Avoid Interactions

Tukysa may interact with other medications, including strong CYP3A inhibitors or inducers, which can affect its effectiveness. Alcohol and certain supplements may also interact; consult a healthcare provider before combining therapies. Grapefruit products should be avoided during treatment.

Frequently Asked Questions

Tukysa is used to treat HER2-positive breast cancer, often in combination with other therapies.

Store at room temperature, away from moisture and heat, and keep out of reach of children.

Consult a healthcare provider before combining Tukysa with other drugs, as interactions may occur.

Common effects may include gastrointestinal discomfort or fatigue, but responses vary by individual.

Tukysa helps manage cancer progression but is not a cure; discuss treatment goals with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.